Replimune Group, Inc. (REPL)
7.65
-0.04
(-0.52%)
USD |
NASDAQ |
Feb 27, 16:00
7.80
+0.15
(+1.96%)
After-Hours: 20:00
Replimune Group Price : 7.65 for Feb. 27, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Sarepta Therapeutics, Inc. | 16.76 |
| Bristol Myers Squibb Co. | 62.37 |
| ACADIA Pharmaceuticals, Inc. | 24.56 |
| Alnylam Pharmaceuticals, Inc. | 332.92 |
| Savara, Inc. | 6.02 |
Price Related Metrics
| PEG Ratio | -0.153 |
| Price to Book Value | 3.000 |
| Earnings Yield | -46.83% |
| Market Cap | 631.68M |
| PEGY Ratio | -0.153 |